Compare · AIXC vs NVO
AIXC vs NVO
Side-by-side comparison of AIxCrypto Holdings Inc. (AIXC) and Novo Nordisk A/S (NVO): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both AIXC and NVO operate in Biotechnology: Pharmaceutical Preparations (Health Care), so they compete in similar markets.
- NVO is the larger of the two at $199.79B, about 12658.2x AIXC ($15.8M).
- AIXC has been more active in the news (11 items in the past 4 weeks vs 8 for NVO).
- NVO has more recent analyst coverage (25 ratings vs 0 for AIXC).
- Company
- AIxCrypto Holdings Inc.
- Novo Nordisk A/S
- Price
- $0.78-3.84%
- $45.13-0.43%
- Market cap
- $15.8M
- $199.79B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Biotechnology: Pharmaceutical Preparations
- Biotechnology: Pharmaceutical Preparations
- Exchange
- NASDAQ
- NYSE
- IPO
- 2015
- News (4w)
- 11
- 8
- Recent ratings
- 0
- 25
Novo Nordisk A/S
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Lund University to develop treatment for Parkinson's diseases; and bluebird bio, Inc. to develop genome editing treatments for children and adult patients. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
Latest AIXC
- AIxC's RoboShare Makes U.S. Robot-Sharing History as Seven Robots Share the Stage with DU$TY and Big
- AIxC Launches RoboShare & Co. North American Dealer Program as First Flywheel Case, Secures One-year $33,000 Robot Rental Order and Expands A Signed FFAI Robot Order to 23 Units
- SEC Form 8-K filed by AIxCrypto Holdings Inc.
- SEC Form 3 filed by new insider Dodier Jason Evan
- AIxCrypto Provides Additional Context on Schedule 14C Filing and Disciplined Capital Strategy to Advance RoboShare's Next Stage of Growth
- AIxC's RoboShare Secures New Short- and Long-Term Orders, Plans to Build North America's Largest and Most Diverse Robot-Sharing Platform
- SEC Form PRE 14C filed by AIxCrypto Holdings Inc.
- Faraday Future Supports AIxC’s Full Strategic Pivot to Physical AI and Robot-Sharing and Rental Operations; RoboShare Completes Its First Paid Commercial Order, With an Initial Fleet of More Than 80 Robots in Place
- Amendment: SEC Form S-1/A filed by AIxCrypto Holdings Inc.
- AIxC Announces Strategic Pivot to Physical AI and Robotic Operations Commercialization; RoboShare Completes First Paid Commercial Order
Latest NVO
- SEC Form 6-K filed by Novo Nordisk A/S
- Novo Nordisk A/S downgraded by Deutsche Bank
- SEC Form 6-K filed by Novo Nordisk A/S
- A New Category Is Forming in Medical Aesthetics. Independent Research Has Started Sizing It.
- SEC Form 6-K filed by Novo Nordisk A/S
- Novo Nordisk A/S downgraded by Berenberg
- SEC Form 6-K filed by Novo Nordisk A/S
- SEC Form 6-K filed by Novo Nordisk A/S
- SEC Form 6-K filed by Novo Nordisk A/S
- SEC Form 6-K filed by Novo Nordisk A/S